Taiho Pharma Europe, Limited

General information

Name:

Taiho Pharma Europe, Ltd

Office Address:

11th Floor, Two Snow Hill B4 6WR Birmingham

Number: 06816012

Incorporation date: 2009-02-11

End of financial year: 31 December

Category: Private Limited Company

Status: Active

Description

Data updated on:

Started with Reg No. 06816012 fifteen years ago, Taiho Pharma Europe, Limited is categorised as a Private Limited Company. The firm's actual mailing address is 11th Floor, Two, Snow Hill Birmingham. The enterprise's registered with SIC code 72110 meaning Research and experimental development on biotechnology. Taiho Pharma Europe, Ltd reported its account information for the financial year up to 2022/12/31. The firm's most recent confirmation statement was released on 2023/04/27.

In the following firm, a variety of director's duties up till now have been met by Atsushi A. and Timothy W.. When it comes to these two individuals, Timothy W. has administered firm for the longest time, having been one of the many members of directors' team for six years.

The companies with significant control over this firm are as follows: Otsuka Holdings Co. Ltd owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Tokyo 101-0048 at Kanda-Tsukasamachi, Chiyoda-Ku and was registered as a PSC under the reg no 0100-01-118786.

Company staff

Atsushi A.

Role: Director

Appointed: 14 March 2023

Latest update: 27 February 2024

Timothy W.

Role: Director

Appointed: 01 April 2018

Latest update: 27 February 2024

People with significant control

Otsuka Holdings Co. Ltd
Address: 2-9 Kanda-Tsukasamachi, Chiyoda-Ku, Tokyo 101-0048, Japan
Legal authority Japanese Law
Legal form Publicly Traded Company
Country registered Japan
Place registered Tokyo Stock Exchange
Registration number 0100-01-118786
Notified on 6 April 2016
Nature of control:
over 3/4 of shares
3/4 to full of voting rights
right to manage directors

Accounts Documents

Account next due date 30 September 2024
Account last made up date 31 December 2022
Confirmation statement next due date 11 May 2024
Confirmation statement last made up date 27 April 2023

Company filings

Filing category

Hide filing type
Accounts Address Annual return Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Free Download
Director's appointment terminated on 2023/03/14 (TM01)
filed on: 26th, May 2023
officers
Free Download Download filing (1 page)

Search other companies

Services (by SIC Code)

  • 72110 : Research and experimental development on biotechnology
15
Company Age

Similar companies nearby

Closest companies